Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Global Blood Therapeutics, Inc. Follow-On Offering

Davis Polk advised the joint book-running managers in connection with the $120 million follow-on offering of common stock of Global Blood Therapeutics, Inc. Global Blood’s common stock is…

Spark Therapeutics Follow-On Offering

Davis Polk advised the representative of the underwriters in connection with the $181 million public offering of 4,025,000 shares of common stock of Spark Therapeutics, Inc. (“Spark”),…
Back to top